ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.

Pages (792): « Previous 1 … 506 507 508 509 510 … 792 Next »

Date & Time	Title
Tue, 19 Nov 2024 00:00:00 +0800	MoEngage is a "Strong Performer" in Q4 2024 Analyst Report on Cross-Channel Marketing Hubs
Tue, 19 Nov 2024 00:00:00 +0800	Black Friday at Retro Stage: Vintage Dreams at the Year's Lowest Prices
Mon, 18 Nov 2024 23:50:00 +0800	Aramco, SINOPEC, and Fujian Petrochemical break ground on new refining and petrochemical project in China
Mon, 18 Nov 2024 23:00:00 +0800	Celebrating Nikki Mudarris: Momcozy and Babylist Host Influencer Shower
Mon, 18 Nov 2024 23:00:00 +0800	Aon Launches Cyber Risk Analyzer to Mitigate Clients' Cyber Risk Exposure
Mon, 18 Nov 2024 22:31:00 +0800	Blue Planet ranks in Forbes India's Select 200 Global Companies
Mon, 18 Nov 2024 22:30:00 +0800	WAT Medical Continues Support for Red Cross and Veterans Association
Mon, 18 Nov 2024 22:26:00 +0800	The Future is Here: ICP Unveils Revolutionary AI-Powered Web Creation Platform
Mon, 18 Nov 2024 22:23:00 +0800	Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Mon, 18 Nov 2024 22:15:00 +0800	Shengfeng Development Limited Announces Joint Venture with Fujian Fulai Aviation to Expand Low-Altitude Logistics Services
Mon, 18 Nov 2024 22:15:00 +0800	Tribesigns Strengthened Partnership with Wayfair at High Point Market 2024
Mon, 18 Nov 2024 22:00:00 +0800	Massimo Announces Expansion of Successful Partnership with Rural King for 2025
Mon, 18 Nov 2024 22:00:00 +0800	C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital
Mon, 18 Nov 2024 22:00:00 +0800	Nintex Introduces Nintex Apps, Enabling Businesses and Partners to Easily Build Engaging Applications that Drive Productivity and Innovation
Mon, 18 Nov 2024 22:00:00 +0800	Is China taking advantage of China-U.S. trade?
Mon, 18 Nov 2024 22:00:00 +0800	Databricks Achieves Authorization for DoD IL5 on AWS GovCloud
Mon, 18 Nov 2024 22:00:00 +0800	Caravelle International Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
Mon, 18 Nov 2024 22:00:00 +0800	Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Mon, 18 Nov 2024 21:53:00 +0800	Jiangxi: Thriving on New Growth Drivers
Mon, 18 Nov 2024 21:50:00 +0800	Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets

Pages (792): « Previous 1 … 506 507 508 509 510 … 792 Next »

Login
Username:
Password:	Lost Password?
	Remember me